Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: Comparison with trisomies and controls

Molecular Human Reproduction

Volumn 16, Issue 10, 2010, Pages 778-789

  von Kaisenberg, C S ^a,b   Wilting, J ^c   Dork T ^a   Nicolaides, K H ^b   Meinhold Heerlein, I ^d   Hillemanns, P ^a   Brand Saberi, B ^e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Aneuploidy; Blood vessels; Lymphatics; Nuchal translucency; Pathophysiology

Indexed keywords

COLLAGEN TYPE 4; LAMININ; VASCULOTROPIN RECEPTOR 3; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD CLOTTING; CAPILLARY BLOOD; FETUS; HUMAN; HUMAN TISSUE; HYPOPLASIA; IMMUNOREACTIVITY; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; STAINING; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME;

CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; DOWN SYNDROME; FEMALE; FETAL DISEASES; FETUS; HUMANS; LYMPHATIC VESSELS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; SKIN; TRISOMY; TURNER SYNDROME;

EID: 77956815008     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gaq035     Document Type: Article

References (65)

1. Abtahian F, Bezman N, Clemens R, Sebzda E, Cheng L, Shattil SJ, Kahn ML, Koretzky GA. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol 2006;26:6936-6949.
2. Abtahian F, Guerriero A, Sebzda E, Lu MM, Zhou R, Mocsai A, Myers EE, Huang B, Jackson DG, Ferrari VA et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003;299:247-251.
3. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-478.
4. Aitkenhead M, Christ B, Eichmann A, Feucht M, Wilson DJ, Wilting J. Paracrine and autocrine regulation of vascular endothelial growth factor during tissue differentiation in the quail. Dev Dyn 1989;212:1-13.
5. Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 2008;1131:1-12.
6. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE 1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
7. Bekker MN, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac. Obstet Gynecol 2006a;108:846-853.
8. Bekker MN, van den Akker NM, Bartelings MM, Arkesteijn JB, Fischer SG, Polman JA, Haak MC, Webb S, Poelmann RE, van Vugt JM et al. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig 2006b;13:209-216.
9. Bekker MN, van den Akker NM, de Mooij YM, Bartelings MM, van Vugt JM, Gittenberger-de Groot AC. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema. Reprod Sci 2008;15:295-304.
10. Böhlandt S, von Kaisenberg CS, Wewetzer C, Christ B, Nicolaides KH, Brand-Saberi B. Hyaluronic acid in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000;15:1155-1158.
11. Castelli E, Todros T, Mattutino G, Torre C, Panattoni G. Light and scanning electron microscope study of nuchal translucency in a normal fetus. Ultrasound Obstet Gynecol 2003;21:514-520.
12. Chitayat D, Kalousek DK, Bamforth JS. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma. Am J Med Genet 1989;33:352-356.
13. Connell FC, Ostergaard P, Carver C, Brice G, Williams N, Mansour S, Mortimer PS, Jeffery S. Lymphoedema Consortium. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet 2009;124:625-631.
14. de Mooij YM, van den Akker NM, Bekker MN, Bartelings MM, Wisse LJ, van Vugt JM, Gittenberger-de Groot AC. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency. Prenat Diagn 2009;29:840-846.
15. François M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008;456:643-647.
16. Fraser JR, Laurent TC. Turnover and metabolism of hyaluronan. Ciba Found Symp 1989;143:41-53.
17. Fraser JR, Kimpton WG, Laurent TC, Cahill RN, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988;256:153-158.
18. Gale NW, Prevo R, Espinosa J, Ferguson DJ, Dominguez MG, Yancopoulos GD, Thurston G, Jackson DG. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol Cell Biol 2007;27:595-604.
19. Ghalamkarpour A, Holnthoner W, Saharinen P, Boon LM, Mulliken JB, Alitalo K, Vikkula M. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet 2009a;46:399-404.
20. Ghalamkarpour A, Debauche C, Haan E, Van Regemorter N, Sznajer Y, Thomas D, Revencu N, Gillerot Y, Boon LM, Vikkula M. Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. J Pediatr 2009b;155:90-93.
21. Gittenberger-de Groot AC, van den Akker NM, Bartelings MM, Webb S, van Vugt JM, Haak MC. Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema. Dev Dyn 2004;230:378-384.
22. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002;17:1086-1092.
23. Hong YK, Shin JW, Detmar M. Development of the lymphatic vascular system: a mystery unravels. Dev Dyn 2004;231:462-473.
24. Huntington GS. The genetic interpretation of the development of the mammalian lymphatic system. Anat Rec 1908;2:19-46.
25. Huntington GS. The development of the mammalian jugular lymph sac, of the primitive ulnar lymphatic and the thoracic ducts from the view point of recent investigations of the vertebrate lymphatic ontogeny, together with a consideration of the genetic relations of lymphatic and haemal vascular channels in embryos of amniotes. Am J Anat 1914;16:259-317.
26. Hyett JA, Moscoso G, Nicolaides KH. Morphometric analysis of the great vessels in early fetal life. Hum Reprod 1995a;10:3045-3048.
27. Hyett JA, Moscoso G, Nicolaides KH. Increased nuchal translucency in trisomy 21 fetuses: relation to narrowing of the aortic isthmus. Hum Reprod 1995b;10:3049-3051.
28. Hyett JA, Moscoso G, Nicolaides KH. Abnormalites of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997;69:207-216.
29. Irrthum A, Karkkainen M, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000;67:295-301.
30. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298.
31. Kaipainen A, Korhonen J, Mustonen T, Van Hinsbergh VWM, Fang GH, Dumont D, Breitman M, Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995;92:3566-3570.
32. Kampmeier OF. The value of the injection method in the study of lymphatic development. Anat Rec 1912;6:223-233.
33. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, Mc Tigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphedema. Nat Genet 2000;25:153-159.
34. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
35. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008;3:367-397.
36. Kato S, Shimoda H, Ji RC, Miura M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 2006;81:71-83.
37. Mäkinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005;19:397-410.
38. Mukai K, Rosai J, Burgdorf WH. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 1980;4:273-276.
39. Nicolaides KH, Brizot ML, Snijders RJM. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994;101:782-786.
40. Norrmén C, Ivanov KI, Cheng J, Zangger N, Delorenzi M, Jaquet M, Miura N, Puolakkainen P, Horsley V, Hu J et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 2009;185:439-457.
41. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1992;52:5738-5743.
42. Papoutsi M, Tomarev SI, Eichmann A, Pröls F, Christ B, Wilting J. Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev Dyn 2001;222:238-251.
43. Partanen TA, Makinen T, Arola J, Suda T, Weich HA, Alitalo K. Endothelial growth factor receptors in human fetal heart. Circulation 1999;100:583-586.
44. Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Ylä-Herttuala S et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nature Med 2004;10:974-981.
45. Polkinghorne J. Review of the Guidance on the Research Use of Fetuses and Fetal Material. London: Her Majesty's Stationary Office, 1989, Cm762.
46. Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI, Wilting J. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol 2001;204:399-406.
47. Sabin FR. The lymphatic system in human embryos, with a consideration of the morphology of the system as whole. Am J Anat 1909;9:43-91.
48. Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Oliver G et al. T1a/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003;22:3546-3556.
49. Sebzda E, Hibbard C, Sweeney S, Abtahian F, Bezman N, Clemens G, Maltzman JS, Cheng L, Liu F, Turner M et al. SYK and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev Cell 2006;11:349-361.
50. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 1994;79:316-322.
51. Snijders RJM, Johnson S, Sebire NJ, Noble PL, Nicolaides KH. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996;7:216-226.
52. Souka AP, Krampl E, Geerts L, Nicolaides KH. Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation. Prenat Diagn 2002;22:91-92.
53. Van der Putte SCJ. Lymphatic malformation in human fetuses. Virchows Arch A 1977;376:233-246.
54. Van der Putte SCJ, Van Limborøgh J. The embryonic development of the main lymphatics in man. Acta Morphol Neerl Scand 1980;18:323-335.
55. Vittay P, Bosze P, Gaal M, Laszlo J. Lymph vessel defects in patients with ovarian dysgenesis. Clin Genet 1980;18:387-391.
56. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in fetuses with trisomy 21, 18 and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 1998a;197:105-124.
57. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998b;91:319-323.
58. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod 1999a;14:823-826.
59. von Kaisenberg CS, Hyett JA. Pathophysiology of increased nuchal translucency. In: Nicolaides KH, Sebire NJ, Snijders RJM, Nicolaides KH (eds). The 11-14 Week Scan. Carnforth, Lancs: The Parthenon Publishing Group Ltd, 1999b, 95-110. Casterton Hall, ISBN 1-85070-743-XUK.
60. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-778.
61. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-1513.
62. Wilting J, Eichmann A, Christ B. Expression of the avian VEGF receptor homologues Quek1 and Quek2 in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development. Cell Tissue Res 1997;288:207-223.
63. Wilting J, Papoutsi M, Schneider M, Christ B. The lymphatic endothelium of the avian wing is of somitic origin. Dev Dyn 2000;217:271-278.
64. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark G, Alitalo K, Tomarev SJ, Niemayer C et al. The transcription factor Prox1 is a marker of lymphatic endothelial cells in normal and diseased human fetuses. FASEB J 2002;16:1271-1273.
65. Zinovieva RD, Duncan MK, Johnson TR, Torres R, Polymeropoulos MH, Tomarev SI. Structure and chromosomal localization of the human homeobox gene Prox 1. Genomics 1996;35:517-522.